Montoya-Ramírez J, Acuña-Cota CF, Sánchez-Lora J, Coronel-Ruilova JM, Ramírez-González D, Rodríguez-Salinas JF, Ramírez-López R

Language: Spanish
References: 8
Page: 73-77
PDF size: 1049.97 Kb.

ABSTRACT

Introduction: obesity represents a global pandemic; some reports mention an incidence of 40%. Metabolic and bariatric surgery (MBS) is the most effective treatment of obesity and associated comorbidities. One objective of MBS is to increase quality of life (QOL) of the obese patient. In Mexico, evaluation of QOL in these patients is scarce or null. Objective: evaluate the impact of MBS in Mexican patients of the Obesity Clinic of the Centro Médico Nacional 20 de Noviembre, ISSSTE, on their QOL with Bariatric Analysis and Reporting Outcome System (BAROS) score. Material and methods: a retrospective longitudinal observational study of patients who underwent MBS surgery (40 patients) was conducted with an evaluation of their QOL at 24 months after their procedure using the BAROS instrument. Results: in the BAROS score, a success rate of 97.5% (39 patients) was obtained. When comparing procedures, a final success rate was found in 100% of the Roux-en-Y Gastric Bypass (RYGB) patients and 96.4% of the Vertical Sleeve Gastrectomy (VGS) patients (p = 1.00, OR = 0.00). Weight loss was measured as Excess Weight Loss Percentage (%EWL) 63.75 ± 19.41 and Total Weight Loss Percentage (%TWL) 34 ± 9.32. Resolution of at least one major comorbidity was found in 64% of patients, and partial improvement was observed in 100% of the patients. Conclusion: MBS significantly improves the quality of life of patients with severe obesity, achieving successful weight loss and resolving associated comorbidities. VGS and RYGB are effective and safe procedures, provided they are selected on a case-by-case basis to meet each patient’s individual needs.

REFERENCES

1. Rivas A, Ocejo S, Sierra M. Evaluación de la calidad de vidaen pacientes sometidos a cirugía de obesidad mórbida.Medicina Universitaria. 2009; 11: 243-246.

2. Tan SYT, Tham KW, Ganguly S et al. The impact of bariatricsurgery compared to medical therapy on health-related qualityof life in subjects with obesity and type 2 diabetes mellitus. ObesSurg. 2021; 31: 829-837. doi: 10.1007/s11695-020-05038-6.

3. Gronroos S, Helmio M, Juuti A et al. Effect of laparoscopicsleeve gastrectomy vs roux-en-y gastric bypass on weight lossand quality of life at 7 years in patients with morbid obesity:the SLEEVEPASS randomized clinical trial. JAMA Surg. 2021;156: 137-146. doi: 10.1001/jamasurg.2020.5666.

4. Kolotkin RL, Crosby RD, Williams GR. Health-related qualityof life varies among obese subgroups. Obes Res. 2002; 10:748-756. doi: 10.1038/oby.2002.102.

5. Junquera BS, Ramírez RL, Camuñas SJ et al. Evaluation ofquality of life, weight loss and evolution of comorbiditiesat 6 years after bariatric surgery. Endocrinol DiabetesNutr (Engl Ed). 2021; 68: 501-508. doi: 10.1016/j.endien.2021.11.010.

6. Arishi AA, Gosadi IM, Hakami IA et al. Bariatric surgeryreduces weight loss, comorbidities prevalence, andimproves quality of life in the southern region of SaudiArabia. Medicina (Kaunas). 2023; 59: 1695. doi: 10.3390/medicina59101695.

7. Castanha CR, Tcbc-Pe ÁABF, Castanha AR et al. Evaluationof quality of life, weight loss and comorbidities of patientsundergoing bariatric surgery. Rev Col Bras Cir. 2018; 45:e1864. Portuguese, English. doi: 10.1590/0100-6991e-20181864.

8. Palacio AA, Díaz-Torrente X, Zancheta C et al. Long-termquality of life in patients with bariatric surgery evaluatedwith BAROS. Rev Med Chil. 2024; 152: 331-339. doi:10.4067/s0034-98872024000300331.